Wen‐Ming Cong
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 1%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Hepatology 53
- Hepatocellular Carcinoma Treatment and Prognosis 49
-
- Cancer, Lipids, and Metabolism 11
- Cancer Genomics and Diagnostics 10
Wen‐Ming Cong
132 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Hepatology 1.2k
- Cancer Research 1.1k
- Oncology 773
- Molecular Biology 1.4k
- Epidemiology 655
Countries citing papers authored by Wen‐Ming Cong
This map shows the geographic impact of Wen‐Ming Cong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Ming Cong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Ming Cong more than expected).
Fields of papers citing papers by Wen‐Ming Cong
This network shows the impact of papers produced by Wen‐Ming Cong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Ming Cong. The network helps show where Wen‐Ming Cong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wen‐Ming Cong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 8 | |
| 3 | 2023 | 6 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 8 | |
| 6 | 2019 | 60 | |
| 7 | 2018 | 25 | |
| 8 | 2018 | 28 | |
| 9 | 2017 | 104 | |
| 10 | 2015 | 1 | |
| 11 | 2015 | 124 | |
| 12 | 2013 | 11 | |
| 13 | 2012 | 13 | |
| 14 | 2010 | 72 | |
| 15 | 2008 | 39 | |
| 16 | 2006 | 2 | |
| 17 | 2005 | 2 | |
| 18 | 2005 | 1 | |
| 19 | [Roles of hepatitis B virus and hepatitis C virus in hepato-carcinogenesis]. | 2003 | 8 |
| 20 | 2001 | 42 |
About Wen‐Ming Cong
Wen‐Ming Cong is a scholar working on Hepatology, Cancer Research, Oncology, Epidemiology and Surgery, having authored 135 papers that have together received 3.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (49 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (38 papers), Liver Disease Diagnosis and Treatment (21 papers), Hepatitis B Virus Studies (18 papers), RNA modifications and cancer (13 papers), Pancreatic and Hepatic Oncology Research (11 papers), Cancer, Lipids, and Metabolism (11 papers) and Cancer Genomics and Diagnostics (10 papers). The work is most often cited by research in Hepatology (1.2k citations), Cancer Research (1.1k citations), Oncology (773 citations), Molecular Biology (1.4k citations) and Epidemiology (655 citations). Wen‐Ming Cong has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Mengchao Wu, Hui Dong, Guang‐Zhi Jin, Long-Hai Feng, Yu-Yao Zhu, Xinyuan Lu, Mengchao Wu, Hong Bu, Jie Chen and Jun Chen. Their work appears in journals such as Hepatology, Oncotarget, Journal of Cancer Research and Clinical Oncology, Hepatology International and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.